
Sign up to save your podcasts
Or


Semi-Annual Recap Episode
In this special episode of Inpatient Update, Dr. Mason Turner looks back at the first 10 episodes and distills the biggest practice-changing lessons from more than 25 recent studies.
If you're new to the show, this is the fastest way to understand what Inpatient Update is all about: practical evidence that changes what hospitalists do on rounds tomorrow.
From pneumonia treatment and antibiotic duration to anticoagulation, flu vaccination, and asymptomatic inpatient hypertension, these are the five changes most likely to improve patient care right now.
#5 Pneumonia Care Should Be More DeliberateThe theme: stop reflexive treatment decisions and individualize care.
Featured Article
Short Versus Longer Antibiotic Duration for Community-Acquired Pneumonia: A Multicenter Target Trial Emulation
Annals of Internal Medicine, 2026
Original Episode:
Shorter CAP Antibiotics + The Cipro QTc Myth — with Dr. Ernest Murray
Supporting Articles
Predicting Benefit from Adjuvant Therapy with Corticosteroids in Community-Acquired Pneumonia: A Data-Driven Analysis of Randomized Trials
Lancet Respiratory Medicine, 2025
Original Episode:
Apixaban vs Rivaroxaban + Steroids in Community-Acquired Pneumonia — with Dr. Adam Jaffe
Associations Between Antibiotic Use and Outcomes in Patients Hospitalized with Community-Acquired Pneumonia and Positive Respiratory Viral Assays
Clinical Infectious Diseases, 2026
Original Episode:
Asymptomatic Inpatient Hypertension + Viral Pneumonia Antibiotics — with Dr. Austin White
Takeaway
For carefully selected, clinically improving patients with community-acquired pneumonia:
The lesson is not "do less."
The lesson is to be more deliberate.
#4 Give Your Heart Failure Patients the Flu Shot Before DischargeFeatured Article
Influenza Vaccination to Improve Outcomes for Patients with Acute Heart Failure (PANDA II)
Lancet, 2025
Original Episode:
SHM Converge 2026 Recap — with Dr. Emily Reams
Takeaway
A one-time intervention that many hospitalized patients still miss.
For patients admitted with heart failure during flu season:
Hospitalization creates an opportunity that should not be missed.
If they're eligible and willing, vaccinate before discharge.
#3 With Blood Thinners, Sometimes Less Is MoreFeatured Article
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC Trial)
New England Journal of Medicine, 2025
Original Episode:
Aspirin Plus Anticoagulation + 7 vs 14 Days for Bacteremia — with Dr. Andres Ospina
Supporting Articles
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism (API-CAT Trial)
New England Journal of Medicine, 2025
Original Episode:
Pilot Episode — Solo
Bleeding Risk with Apixaban vs Rivaroxaban in Acute Venous Thromboembolism
New England Journal of Medicine, 2026
Original Episode:
Apixaban vs Rivaroxaban + Steroids in Community-Acquired Pneumonia — with Dr. Adam Jaffe
Takeaway
Several recent studies point in the same direction:
Less anticoagulation is not always better.
But less unnecessary anticoagulation often is.
#2 We Are Entering an Era of Shorter Antibiotic DurationsFeatured Article
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections (BALANCE Trial)
New England Journal of Medicine, 2025
Original Episode:
Aspirin Plus Anticoagulation + 7 vs 14 Days for Bacteremia — with Dr. Andres Ospina
Supporting Articles
Antibiotic De-escalation in Adults Hospitalized for Community-Onset Sepsis
JAMA Internal Medicine, 2026
Original Episode:
De-escalating Sepsis Antibiotics + When to Pull the IV — with Nicholas Linde, PA
Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial
JAMA, 2025
Original Episode:
Faster Hypernatremia Correction + Long-Acting Antibiotics for Staph Bacteremia — with Dr. Kevin Baker
Takeaway
Across multiple infections, the trend is consistent:
The question is no longer:
"Can we shorten antibiotics?"
The question is:
"Why are we still giving so many patients long courses?"
#1 Stop Treating Asymptomatic Inpatient Blood Pressure NumbersFeatured Article
As-Needed Blood Pressure Medication and Adverse Outcomes in VA Hospitals
JAMA Internal Medicine, 2025
Original Episode:
Asymptomatic Inpatient Hypertension + Viral Pneumonia Antibiotics — with Dr. Austin White
Takeaway
This was the most practice-changing study discussed on the show so far.
For hospitalized patients with:
The reflexive response should not be:
"What PRN should I give?"
Instead ask:
Acute treatment of asymptomatic inpatient hypertension was associated with:
Treat the patient.
Not the number.
Bottom LineIf you change nothing else from the first six months of Inpatient Update:
Small changes.
Huge reach.
Real impact.
Support the show
Want the cited articles and key takeaways? Join the email list:
https://subscribe.inpatientupdate.com/
By Mason Turner, MDSemi-Annual Recap Episode
In this special episode of Inpatient Update, Dr. Mason Turner looks back at the first 10 episodes and distills the biggest practice-changing lessons from more than 25 recent studies.
If you're new to the show, this is the fastest way to understand what Inpatient Update is all about: practical evidence that changes what hospitalists do on rounds tomorrow.
From pneumonia treatment and antibiotic duration to anticoagulation, flu vaccination, and asymptomatic inpatient hypertension, these are the five changes most likely to improve patient care right now.
#5 Pneumonia Care Should Be More DeliberateThe theme: stop reflexive treatment decisions and individualize care.
Featured Article
Short Versus Longer Antibiotic Duration for Community-Acquired Pneumonia: A Multicenter Target Trial Emulation
Annals of Internal Medicine, 2026
Original Episode:
Shorter CAP Antibiotics + The Cipro QTc Myth — with Dr. Ernest Murray
Supporting Articles
Predicting Benefit from Adjuvant Therapy with Corticosteroids in Community-Acquired Pneumonia: A Data-Driven Analysis of Randomized Trials
Lancet Respiratory Medicine, 2025
Original Episode:
Apixaban vs Rivaroxaban + Steroids in Community-Acquired Pneumonia — with Dr. Adam Jaffe
Associations Between Antibiotic Use and Outcomes in Patients Hospitalized with Community-Acquired Pneumonia and Positive Respiratory Viral Assays
Clinical Infectious Diseases, 2026
Original Episode:
Asymptomatic Inpatient Hypertension + Viral Pneumonia Antibiotics — with Dr. Austin White
Takeaway
For carefully selected, clinically improving patients with community-acquired pneumonia:
The lesson is not "do less."
The lesson is to be more deliberate.
#4 Give Your Heart Failure Patients the Flu Shot Before DischargeFeatured Article
Influenza Vaccination to Improve Outcomes for Patients with Acute Heart Failure (PANDA II)
Lancet, 2025
Original Episode:
SHM Converge 2026 Recap — with Dr. Emily Reams
Takeaway
A one-time intervention that many hospitalized patients still miss.
For patients admitted with heart failure during flu season:
Hospitalization creates an opportunity that should not be missed.
If they're eligible and willing, vaccinate before discharge.
#3 With Blood Thinners, Sometimes Less Is MoreFeatured Article
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC Trial)
New England Journal of Medicine, 2025
Original Episode:
Aspirin Plus Anticoagulation + 7 vs 14 Days for Bacteremia — with Dr. Andres Ospina
Supporting Articles
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism (API-CAT Trial)
New England Journal of Medicine, 2025
Original Episode:
Pilot Episode — Solo
Bleeding Risk with Apixaban vs Rivaroxaban in Acute Venous Thromboembolism
New England Journal of Medicine, 2026
Original Episode:
Apixaban vs Rivaroxaban + Steroids in Community-Acquired Pneumonia — with Dr. Adam Jaffe
Takeaway
Several recent studies point in the same direction:
Less anticoagulation is not always better.
But less unnecessary anticoagulation often is.
#2 We Are Entering an Era of Shorter Antibiotic DurationsFeatured Article
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections (BALANCE Trial)
New England Journal of Medicine, 2025
Original Episode:
Aspirin Plus Anticoagulation + 7 vs 14 Days for Bacteremia — with Dr. Andres Ospina
Supporting Articles
Antibiotic De-escalation in Adults Hospitalized for Community-Onset Sepsis
JAMA Internal Medicine, 2026
Original Episode:
De-escalating Sepsis Antibiotics + When to Pull the IV — with Nicholas Linde, PA
Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial
JAMA, 2025
Original Episode:
Faster Hypernatremia Correction + Long-Acting Antibiotics for Staph Bacteremia — with Dr. Kevin Baker
Takeaway
Across multiple infections, the trend is consistent:
The question is no longer:
"Can we shorten antibiotics?"
The question is:
"Why are we still giving so many patients long courses?"
#1 Stop Treating Asymptomatic Inpatient Blood Pressure NumbersFeatured Article
As-Needed Blood Pressure Medication and Adverse Outcomes in VA Hospitals
JAMA Internal Medicine, 2025
Original Episode:
Asymptomatic Inpatient Hypertension + Viral Pneumonia Antibiotics — with Dr. Austin White
Takeaway
This was the most practice-changing study discussed on the show so far.
For hospitalized patients with:
The reflexive response should not be:
"What PRN should I give?"
Instead ask:
Acute treatment of asymptomatic inpatient hypertension was associated with:
Treat the patient.
Not the number.
Bottom LineIf you change nothing else from the first six months of Inpatient Update:
Small changes.
Huge reach.
Real impact.
Support the show
Want the cited articles and key takeaways? Join the email list:
https://subscribe.inpatientupdate.com/